Machine learning based predictive model for cardiovascular disease mortality risk in patients with stage 4 cardiovascular–kidney–metabolic syndrome
Patients with stage 4 cardiovascular–kidney–metabolic (CKM) syndrome are exposed to an elevated cardiovascular disease (CVD) mortality risk. However, large-sample, multidimensional prediction models for CVD mortality risk that integrate clinical indicators, as well as highly applicable supporting tools, remain lacking....